Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Mologic
Mologic
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Mologic’s COVID-19 self-test selected for RADx initiative funding
The initiative was launched by the US National Institutes of Health to accelerate the development, commercialisation and implementation of technologies for COVID-19 testing
Finance
Avacta and Mologic announce commercial partnership
Clinical evaluation of the lateral flow test is currently being carried out at a hospital in mainland Europe and Avacta will shortly initiate further clinical validation studies in the UK and abroad
Research & Development
Mologic launches rapid diagnostic test for fungal crop pathogen Botrytis
The company developed and trialled BotrytisAlert with Berry Garden Growers, NIAB EMR and the Warwickshire College
Research & Development
Mologic completes new ultra-sensitive rapid diagnostic test
The next phase of development will include setting up local manufacturing facilities in areas with need of the device for preventing the spread of epidemics
Pharmaceutical
Mologic expands US and UK operations
The UK-based company that develops lateral flow and rapid diagnostic technologies has made multiple appointments in order to bolster US presence
Subscribe now